The Future of Osteoarthritis Therapeutics in Healthcare and Pharmaceuticals Industry
Rapid growth in the geriatric and obese population and the associated increase in the prevalence of osteoarthritis disease. Risk of adverse cardiovascular events associated with the use of NSAIDs in osteoarthritis treatment is likely to hamper the growth of the market. The osteoarthritis therapeutics market is expected to grow from USD 6.8 billion in 2019 to reach USD 10.1 billion by 2024, at a CAGR of 8.1%. Knee segment to witness the highest growth during the forecast period Based on anatomy, the market is segmented into knee, hip, hand, and small-joint. The knee osteoarthritis segment accounted for the largest market share in 2018 and is expected to register the highest CAGR during the forecast period. This is attributed to a large number of patients suffering from knee osteoarthritis. Download PDF Brochure on Osteoarthritis Therapeutics Market Viscosupplementation agents segment to dominate the osteoarthritis therapeutics market in 2018 Based on drug type, the market is ...